Cart
sales@molnova.com
Gedatolisib
CAS No. 1197160-78-3
Gedatolisib( PF-05212384 | PKI-587 )
Catalog No. M10696 CAS No. 1197160-78-3
A highly potent, selective, dual PI3K/mTOR inhibitor.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 43 | In Stock |
|
| 5MG | 68 | In Stock |
|
| 10MG | 116 | In Stock |
|
| 25MG | 226 | In Stock |
|
| 50MG | 416 | In Stock |
|
| 100MG | 617 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1293 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameGedatolisib
-
NoteResearch use only, not for human use.
-
Brief DescriptionA highly potent, selective, dual PI3K/mTOR inhibitor.
-
DescriptionA highly potent, selective, dual PI3K/mTOR inhibitor with IC50 of 0.4/6/8/6/1.6 nM for PI3Kα/β/γ/δ/mTOR, respectively; also potently inhibits PI3Kα mutant H1047R and E545K with IC50 of 0.6 and 0.6 nM; prevents the pAkt at Thr 308 with IC50 of 8 nM, and suppresses pAkt S473 with IC50 of <10 nM in cells; demonstrates antitumor efficacy in both subcutaneous and orthotopic xenograft tumor models.Blood Cancer Phase 3 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsPF-05212384 | PKI-587
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptormTOR|PI3Kα|PI3Kγ
-
Research AreaCancer
-
IndicationBlood cancer
Chemical Information
-
CAS Number1197160-78-3
-
Formula Weight615.72
-
Molecular FormulaC32H41N9O4
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(NC1=CC=C(C2=NC(N3CCOCC3)=NC(N4CCOCC4)=N2)C=C1)NC5=CC=C(C(N6CCC(N(C)C)CC6)=O)C=C5
-
Chemical Name1-(4-{[4-(Dimethylamino)-1-piperidinyl]carbonyl}phenyl)-3-{4-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]phenyl}urea
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Venkatesan AM, et al. J Med Chem. 2010 Mar 25;53(6):2636-45.
2. Mallon R, et al. Clin Cancer Res. 2011 May 15;17(10):3193-203.
3. Gedaly R, et al. J Surg Res. 2013 Nov;185(1):225-30.
4. D'Amato V, et al. Br J Cancer. 2014 Jun 10;110(12):2887-95.
molnova catalog
related products
-
mTOR inhibitor 9d
mTOR inhibitor 9d is a dual inhibitor of the protein kinases mTOR and PI3K with an mTOR IC50 value of 0.31 nm, and can be used for the treatment of leukemia, skin cancer, breast cancer, lung cancer and colon cancer.
-
GDC-0326
A potent, selective, orally available PI3Kα inhibitor with Ki of 0.2 nM; displays 133, 20 and 33-fold selectivity over PI3Kβ, PI3Kδ and PI3Kγ, respectively.
-
PI3Kβ and δ inhibito...
A potent, highly selective PI3Kβ/δ inhibitor with IC50 of 7.8/5.3 nM respectively.
